Composition:

Each Vial Contains:
Methylprednisolone Sodium Succinate U.S.P
Eq. to Anhydrous Methylprednisolone 40 mg.

Indications:

-In ARDS Caused by COVID-19
-In Status asthmaticus
-In Anaphylactic Reactions
-Severe erythema Multiforme
-In Critical regional enteritis & Ulcerative Colitis

Profile:

methylprednisolone acetate is an anti-inflammatory glucocorticoid

Dosage Form:

Dry powder for Injection in a glass Vial with Sterile Water for Injection IP.
Methylprednisolone sodium succinate 40/125/500/1000 mg injection